Regarding non-malignant neurodegenerative diseases, somatic mutations have been recently described in AD brain specimens and were found enriched in PI3K-AKT, MAPK, and AMPK pathway genes known to contribute to hyperphosphorylation of tau. Here, MAPT is linked to Alzheimer disease.